title: Effect of nabumetone treatment on vascular responses of the thoracic aorta in rat experimental arthritis.
abstract: Nabumetone is a nonsteroidal anti-inflammatory (NSAI) drug which is known to cause less gastrointestinal damage than other NSAI drugs. This study was performed to evaluate whether nabumetone treatment might alter the vascular aberrations related to inflammation in a rat model of adjuvant-induced arthritis. Nabumetone treatment (120 or 240 mg x kg(-1) x day(-1), orally) was initiated on the 15th day of adjuvant inoculation and continued for 14 days. Arthritic lesions, vascular contractile and relaxant responses and gastroduodenal histopathological preparations were evaluated 29 days after adjuvant inoculation. The contractile responses of aortic rings to phenylephrine and KCl were increased in grade 2 arthritic rats. In grade 3 arthritis only the phenylephrine contractility was decreased. The relaxant responses to acetylcholine and sodium nitroprusside were decreased in grades 2 and 3. In healthy rats, nabumetone did not change the vascular responses. After treatment of arthritic rats with nabumetone, both the contractile and relaxant response of the aortic rings returned to normal, and arthritic score and paw swelling were reduced. Gastroduodenal histopathology did not show erosions or ulcers in any of the groups. In conclusion, nabumetone improved the systemic signs and vascular alterations in experimental arthritis without showing any gastrointestinal side effects.
authors.affiliation: Department of Pharmacology, Faculty of Medicine, Ege University, Bornova, Izmir, Turkey.
authors.forename: S
authors.initials: S
authors.lastname: Ulker
authors.forename: A
authors.initials: A
authors.lastname: Onal
authors.forename: F B
authors.initials: FB
authors.lastname: Hatip
authors.forename: A
authors.initials: A
authors.lastname: Sürücü
authors.forename: M
authors.initials: M
authors.lastname: Alkanat
authors.forename: S
authors.initials: S
authors.lastname: Koşay
authors.forename: A
authors.initials: A
authors.lastname: Evinç
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology* / Q000627:therapeutic use; D001013:Aorta, Thoracic / Q000187:drug effects*; D001169:Arthritis, Experimental / Q000188:drug therapy; D002074:Butanones / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D000077430:Nabumetone; D051381:Rats; D017208:Rats, Wistar; D014661:Vasoconstriction / Q000187:drug effects*; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D000077430:Nabumetone